JAKARTA - Spokesperson for the COVID-19 Vaccination Ministry of Health (Kemenkes) Siti Nadia Tarmizi said the government continues to try to maintain the availability of COVID-19 therapeutic drugs.
"The Ministry of Health continues to carry out routine coordination with both the pharmaceutical industry and its distribution network to monitor the availability of drugs needed to treat COVID-19," said Siti Nadia in a virtual press conference of the Emergency PPKM daily quoted by Antara, Friday, July 9.
Regarding supply constraints from abroad, Nadia said the Ministry of Health has also coordinated with the Ministry of Foreign Affairs and other relevant ministries to help resolve the issue.
The availability of COVID-19 therapeutic drugs in Indonesia in the pharmaceutical industry and pharmaceutical wholesalers as of July 9, 2021 is Favipiravir as much as 3.2 million, Remdesivir injection 11,000, Oseltamivir 157,000, Azithromycin oral 2.4 million and infusion 163,000, Tocilizumab infusion 543, Intravenous Immunoglobulin 7,000, and oral Ivermectin 237,000.
"The availability of medicines for COVID-19 is continuously increased and their production is added to ensure their availability in the field," said Nadia.
Regarding drug prices, the Ministry of Health has also issued a circular to regulate the highest retail price of drugs.
On this occasion, Nadia also explained that the government also continues to ensure the availability of oxygen supply for COVID-19 treatment. His party has received a commitment from the industrial sector and the Ministry of Industry so that 90 percent of oxygen use will be intended for medical purposes.
In addition, assistance was also provided by several countries such as Australia, China and Singapore which will help fill oxygen and other medical and non-medical equipment amid a significant spike in new cases of COVID-19.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)